Huseyin Salih Semiz

15PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyMolecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|May 21, 2026
Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

|Jan 10, 2026
Evaluating the effect of CD47 expression levels and clinicopathologic features on survival function in resected uterine carcinosarcoma: the Western Turkey example.

Murat Keser, Huseyin Salih Semiz, Ilker Cakir

|Sep 27, 2025
Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs.

Faruk Recep Özalp, Ece Şahin Hafızoğlu, Ahmet Melih Arslan

|Sep 26, 2025
Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.

Seyhmus Abakay, Hüseyin Döngelli, Nilay Danış

Pageof 3

Frequent Collaborators

4 joint publications

Merve Keskinkılıç

3 joint publications

Sedat Biter

3 joint publications

Olcun Umit Unal

3 joint publications

Tugba Yavuzsen